Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Cambrex Announces Sale of Drug Product Business Unit
Contributed by:
PR Newswire
Images
Tags
Cambrex
More Like This
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
Cambrex Expands Peptide Manufacturing Capabilities in Waltham, Massachusetts
Cambrex Completes $38 Million Capacity Expansion in High Point, North Carolina
Snapdragon Chemistry, a Cambrex Company, Recognized with CPhI Pharma Award for API Development
Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology
Cambrex Opens New Stability Storage Facility in Durham, North Carolina
Cambrex to Expand Stability Storage Business with New Facility in Durham, North Carolina
